This figure corresponds to the Average Price over the previous 50/200 days.
For BioNTech stocks, the 50-day moving average is the resistance level today.
For BioNTech stocks, the 200-day moving average is the resistance level today.
Are you interested in BioNTech SE stocks and want to buy them, or are they already in your portfolio?
If yes, then on this page you will find useful information about the dynamics of the BioNTech
stock price in 2024, 2025, 2026, 2027, 2028.
How much will one BioNTech share be worth in
2024 - 2028?
When should I take profit in BioNTech stock?
When should I record a loss on BioNTech stock?
What are analysts' forecasts for BioNTech stock?
What is the future of BioNTech stock?
We forecast BioNTech stock performance using neural networks based on historical data on BioNTech stocks.
Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
BioNTech stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals.
(Next month, 2024, 2025, 2026, 2027 and 2028)
The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for BioNTech shares. This happens once a day.
Historical and forecast chart of BioNTech stock
The chart below shows the historical price of BioNTech stock and a prediction chart for the next month.
For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast,
and Weighted Average Best Forecast. Detailed values for the BioNTech stock price can be found in the table below.
Long-term forecasts by years.
BioNTech SE is a German biotechnology company that develops and manufactures active immunotherapeutic agents for an individual approach to the treatment of serious diseases. The company is investigating messenger RNA (mRNA) -based drugs for use as individualized immunotherapy for cancer, as vaccines against infectious diseases and as protein replacement therapy for rare diseases, as well as developed cell therapy, new antibodies and small molecules, immunomodulators, as options cancer treatment. The company has developed an intravenous mRNA-based human therapeutic drug to bring individualized mRNA-based cancer immunotherapy to clinical trials and establish its own manufacturing process.
Trending Themes in the Healthcare Sector
BioNTech daily forecast for a month
Date
Target
Pes.
Opt.
Vol., %
Dec 05
99.69
98.19
102.86
4.75
Dec 06
97.66
96.42
99.06
2.73
Dec 07
92.50
90.00
94.72
5.24
Dec 08
92.83
90.05
96.34
6.99
Dec 09
92.00
89.40
94.04
5.19
Dec 10
94.92
90.82
99.19
9.22
Dec 11
96.57
94.43
100.57
6.50
Dec 12
98.72
96.17
102.98
7.08
Dec 13
101.21
99.50
102.91
3.42
Dec 14
99.38
97.95
101.23
3.35
Dec 15
96.16
92.12
98.88
7.33
Dec 16
98.47
94.75
100.84
6.42
Dec 17
95.75
91.90
99.66
8.44
Dec 18
96.67
95.34
100.91
5.84
Dec 19
101.60
99.71
105.69
5.99
Dec 20
103.07
99.05
107.09
8.12
Dec 21
101.27
96.59
105.22
8.93
Dec 22
104.62
103.11
108.07
4.81
Dec 23
104.93
102.22
107.26
4.93
Dec 24
103.42
99.45
106.83
7.42
Dec 25
104.97
101.82
107.24
5.32
Dec 26
99.93
95.85
101.55
5.94
Dec 27
103.65
99.05
106.63
7.66
Dec 28
101.04
96.43
104.31
8.17
Dec 29
105.46
102.80
110.08
7.08
Dec 30
102.36
100.27
105.98
5.70
Dec 31
98.61
96.60
100.86
4.41
Jan 01
96.96
94.63
98.47
4.06
Jan 02
95.10
91.22
97.61
7.01
Jan 03
96.41
93.63
97.57
4.20
BioNTech Daily Price Targets
BioNTech Stock Forecast 12-05-2023.
Forecast target price for 12-05-2023: $99.69. Positive dynamics for BioNTech shares will prevail with possible volatility of 4.536%. Pessimistic target level: 98.19 Optimistic target level: 102.86
BioNTech Stock Forecast 12-06-2023.
Forecast target price for 12-06-2023: $97.66. Negative dynamics for BioNTech shares will prevail with possible volatility of 2.662%. Pessimistic target level: 96.42 Optimistic target level: 99.06
BioNTech Stock Forecast 12-07-2023.
Forecast target price for 12-07-2023: $92.50. Negative dynamics for BioNTech shares will prevail with possible volatility of 4.980%. Pessimistic target level: 90.00 Optimistic target level: 94.72
BioNTech Stock Forecast 12-08-2023.
Forecast target price for 12-08-2023: $92.83. Positive dynamics for BioNTech shares will prevail with possible volatility of 6.533%. Pessimistic target level: 90.05 Optimistic target level: 96.34
BioNTech Stock Forecast 12-09-2023.
Forecast target price for 12-09-2023: $92.00. Negative dynamics for BioNTech shares will prevail with possible volatility of 4.931%. Pessimistic target level: 89.40 Optimistic target level: 94.04
BioNTech Stock Forecast 12-10-2023.
Forecast target price for 12-10-2023: $94.92. Positive dynamics for BioNTech shares will prevail with possible volatility of 8.440%. Pessimistic target level: 90.82 Optimistic target level: 99.19
Market capitalization of the BioNTech SE is the total market value of all issued shares of a company. It is calculated by the formula
multiplying the number of BNTX shares in the company outstanding by the market price of one share.
EBITDA:
5 939 800 000 $
EBITDA of BioNTech is earnings before interest, income tax and depreciation of assets.
PE Ratio:
5.22
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
PEG Ratio:
0.0449
Price/earnings to growth
DPS:
N/A
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
DY:
0.0132
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS:
19.04
EPS shows how much of the net profit is accounted for by the common share.
Quarterly Earnings Growth YOY:
-0.856
Quarterly Revenue Growth YOY:
-0.948
Trailing PE:
5.22
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward PE:
34.13
Forward P/E uses projections of future earnings instead of final numbers.
EV To Revenue:
0.706
Enterprise Value (EV) /Revenue
EV To EBITDA:
1.073
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Shares Outstanding:
239771000
Number of issued ordinary shares
Shares Float:
N/A
Number of freely tradable shares
Shares Short Prior Month:
N/A
Shares Short Prior Month - the number of shares in short positions in the last month.
Short Ratio:
N/A
Percent Insiders:
N/A
Percent Institutions:
N/A
BioNTech (BNTX) stock dividend
BioNTech last paid dividends on 06/02/2022.
The next scheduled payment will be on 06/17/2022.
The amount of dividends is $0 per share.
If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment.
As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.
Last Split Factor:
Last Split Date:
01/01/1970
Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.
For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times.
It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and,
moreover, are not trading signals.
When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market
as a result of using the information contained on the site.
This website uses cookies to ensure you get the best experience on our website